Header

Suche
Vetsuisse-Fakultät

Grants

  Collaborators Funding
PET4PETs
We will build a new generation of multi-tracer PET to improve staging and allow screening for personalized target based cancer therapy in dogs and humans affected by sarcoma.		 Institut für Teilchenphysik ETH / Radiopharmazie des Paul Scherrer Institut Kantonsspital Baden /Universitätsspital Zürich / Kantonsspital Baden SNF
2025-2029
Personalizing hypo- and ultra-hypofractionated radiotherapy  
We leverage spontaneous canine tumors to develop an RNAseq-derived fraction-dynamic radiosentitivity signature		 Medizinphysik (Radiotherapie Hirslanden, Physik UZH) / Applied Complex Systems Scientists der ZHAW SNF
2025-2029
Deciphering the STS-landscape
We combine spatially defined transcriptomics with clinical outcome data to improve diagnosis and therapy of canine soft-tissue sarcoma		   American Kennel Club

FEATHER-trial (phase II/III randomized trial)
We assess toxicity and efficacy of ultra-high dose rate (FLASH) vs. conventional dose rate proton therapy in feline oral squamous cell carcinoma to model human H&N tumors

 

 Paul Scherrer Institut / Oncology Department, HUG Swiss Cancer Research
2023-2026

vISION-S (Phase III randomized trial)
We make naturally occurring sacromas in dogs visible during surgery using two different dyes. The aim ist o determine which one can help best to improve precision of resection.
10.17590/asr.0000321

 Institute for Veterinary Pathology Vetsuisse Zürich (Frauke und Paula verlinken), MEEI Institute Harvard University

SNF 2025-2028

Gesellschaft für Kynologische Forschung (2023-2026)
DECODE-AS (ex-vivo)
We sequence hemangiosarcoma to detect new diagnostic and therapeutic targets.		 Institute for Veterinary Pathology Vetsuisse Zürich Morris Foundation D24CA-044 (2024-2026)
Charakterisierung von Tumor spezifischen Proteinsignaturen zur Ziel-gerichteten Tumortherapie beim soliden und disseminierten Histiozytären Sarkom.
We sequence histiocytic sarcoma to detect new diagnostic and therapeutic targets.
 		 Institute for Veterinary Pathology Vetsuisse Zürich Albert-Heim Stiftung (2023-2026), American Kennel Club (2024-2027)

Vergleichende Untersuchung von Indocyanin Grün und AngiostampTM zur Verbesserung der chirurgischen Therapie bei Hunden mit peripheren Nervenscheidentumoren des Plexus Brachialis oder Lumbalis.
We make naturally occurring sacromas of the great nerves (plexustumors)  in dogs visible during surgery using two different dyes. The aim ist o determine which one can help best to improve precision of resection.

10.17590/asr.0000320

 Institute for Veterinary Pathology Vetsuisse Zürich Gesellschaft zur Förderung kynologischer Forschung